Author(s): Shweta Padher, Vinayak Walhekar, Ravindra Kulkarni, Varsha Pokharkar

Email(s): varsha.pokharkar@bharatividyapeeth.edu

DOI: 10.52711/0974-360X.2025.00036   

Address: Shweta Padher, Vinayak Walhekar, Ravindra Kulkarni, Varsha Pokharkar*
Bharati Vidyapeeth (Deemed to be University), Poona College of Pharmacy, Erandwane, Pune 411 038, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 18,      Issue - 1,     Year - 2025


ABSTRACT:
Non-alcoholic fatty liver disease (NAFLD) has gradually become one of the most common liver diseases in the world, with high global occurrence whilst lacking the presence of effective treatment strategies. Herbal medicines known as “nature’s pharmacy” are an important component of all indigenous conventional therapies. A wide variety of herbal formulations are available in the market for varied uses, but limited bioavailability and scarce information of their ADME properties restrict their use and application. Experimental and computational approaches have hence now been readily employed to minimise the cost, time, and risk involved in the new drug discovery. In the current study, we have employed similar computational approaches to identify the target proteins of NAFLD i.e. (peroxisome proliferator-activated receptors )PPAR-a and PPAR-?,which are the most well-known anti-obesity transcription factor found in the adipose and liver, followed by use of in-silicoand molecular docking analysis tools, to select the appropriate phyto-constituents for further formulation and evaluation. A reverse pharmacology based approach to identify phyto-constituents and the analysing of their in-silicoADME properties and binding actions on the PPARs by using docking studies were hence the aim of the current study. Identification of the important protein targets i.e PPAR-a, PPAR- ?, in-silico ADME analysis and screening, followed by molecular docking studies yielded Silymarin and Glycyrrhizic acid as the final lead molecules for further studies(-8.6,-8.4,-8.3,-8.9 kcal/mol respectively).The docking energies for each protein-ligand complex provided the insights that these said phytomolecules can further be used for studying their use as potential therapeutic agents for the alleviation of NAFLD.


Cite this article:
Shweta Padher, Vinayak Walhekar, Ravindra Kulkarni, Varsha Pokharkar. Computational based in-silico and molecular docking approach for screening of phyto-constituents on PPAR targets in the treatment of NAFLD. Research Journal of Pharmacy and Technology. 2025;18(1):232-8. doi: 10.52711/0974-360X.2025.00036

Cite(Electronic):
Shweta Padher, Vinayak Walhekar, Ravindra Kulkarni, Varsha Pokharkar. Computational based in-silico and molecular docking approach for screening of phyto-constituents on PPAR targets in the treatment of NAFLD. Research Journal of Pharmacy and Technology. 2025;18(1):232-8. doi: 10.52711/0974-360X.2025.00036   Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-1-36


REFERENCES:
1.    Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020; May; 158(7): 1851-64. doi: 10.1053/j.gastro.2020.01.052.
2.    Dietrich CG, Rau M, Geier A. Screening for nonalcoholic fatty liver disease-when, who and how? World J Gastroenterol. 2021; Sep. 21; 27(35): 5803-821. doi: 10.3748/wjg.v27.i35.5803
3.    Younossi, Z., Anstee, Q., Marietti, M. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018.15; 11–20. doi: 10.1038/nrgastro.2017.109
4.    Sun, C.-Y,Zhao, P,Yan,P.-Z, Li, J.,Zhao,D.-S. Investigation of Lonicera japonica Flos against Nonalcoholic Fatty Liver Disease Using Network Integration and Experimental Validation. Medicina 2022; 58; 1176. doi: 10.3390/medicina58091176
5.    Abenavoli, L.; Falalyeyeva, T.; Boccuto, L.; Tsyryuk, O.; Kobyliak, N. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease. Pharmaceuticals. 2018; 11; 104. doi: 10.3390/ph11040104.
6.    Petta S, Valenti L, Bugianesi E, Targher G, Bellentani S, Bonino F. A “systems medicine” approach to the study of non-alcoholic fatty liver disease.Digestive Liver Disease. 2016; 48: 333–42. doi: 10.3748/wjg.v23.i36.6571
7.    Yoshio Sumida  Masashi Yoneda.Current and future pharmacological therapies for NAFLD/NASH.J Gastroenterol. 2018; 53: 362–76. doi: 10.1007/s00535-017-1415-1
8.    Malênia Oliveira dos Santos Coelho.Momordica charantia and breast cancer: An in silico approach, Journal of Theoretical and Computational Chemistry. 2050015. doi:10.1142/S0219633620500157
9.    Borse S, Joshi M, Saggam A, Bhat V, Walia S, Marathe A, et al. Ayurveda botanicals in COVID-19 management: An in silico multi-target approach. PLoS ONE. 2021; 16(6): e0248479. doi: 10.1371/journal.pone.0248479. eCollection 2021.
10.    Yiqiong Pu, Xitong Zhang .20(S)-Protopanaxadiol Phospholipid Complex: Process Optimization, Characterization, In Vitro Dissolution and Molecular Docking Studies Molecules. 2016; 21, 1396.doi: 10.3390/molecules21101396
11.    Arash Arya, Nahid Azarmehr, Mahboubeh Mansourian and Amir Hossein Doustimotlagh.Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies, Archives of Physiology and Biochemistry. 2019; doi: 10.1080/13813455.2019.1659827
12.    Shan-shan Gao , Ji-jia Sun.Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.doi:10.1155/2020/1704960
13.    Wen-Yi Hu,a,b Xiao-Hui Ma.Preventive effect of Silibinin in combination with Pu-erh tea extract on non-alcoholic fatty liver disease in ob/ob mice, Food Funct. 2017; 1105–15. doi: 10.1039/c6fo01591c
14.    Daina A, Michielin O, Zoete V, SwissADME:a free web tool to evaluate pharmacokinetics, drug- likeness and medicinal chemistry friendliness of small molecules, Scientific Reports. 2017; doi: 10.1038/srep42717
15.    Gfeller D, Grosdidier A, Wirth M, Daiana A, Michielin O, Zoete V, Swiss Target Prediction: A web server for target prediction of bioactive small molecules. Nucleic Acids Res. 2014; 42: 32–38. doi: 10.1093/nar/gku293
16.    Lipinski CA, Drug like properties and the causes of poor solubility and poor permeability,Journal of pharmacological and Toxicological methods.44. 2000; 235-249. doi: 10.1016/s1056-8719(00)00107-6
17.    Lipinski CA, Lombardo F, Dominy BW, Feeney PJ, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Advanced drug delivery reviews., 2001. 46: 3–26. doi:10.1016/s0169-409x(00)00129-0
18.    C. Girish, S.C. Pradhan.Herbal Drugs on the Liver. Chapter 44 SECTION VI.Therapies in Liver Disease Liver Pathophysiology 2017
19.    Arrigo F. G. Cicero, Alessandro Colletti and Stefano Bellentani Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence. Nutrients 2018; 10, 1153. doi: 10.3390/nu10091153
20.    M. Sravani, P. Sai Lakshmi, K. Amuktha Reddy, Naga Deepthi N, Uday Sasi Kiran Kantheti. Insilico Analysis and Docking of Tacrine and Donepezil Derivatives Targeting Histamine-N-Methyltransferase and Acetyl Cholinesterase Protein Respectively for Alzheimer's Disease. Research J. Pharm. and Tech. 2013; 6(1): Jan. 86-89.
21.    Sandeep Reddy CH, Sree Kumar Reddy G., Manoj Kumar Mahto, Pavan Kunala, Chaitanya Kanth R. Insilico Design and Discovery of Some Novel Ache Inhibitors for Treatment of Alzheimer’s Disorder. Research J. Pharm. and Tech. 2012; 5(3): Mar. 424-427.
22.    K. Girija, B. Jamuna. Design and Synthesis of Some Novel Schiff’s Base Aryl Imidazole Derivatives, Characterization, Docking and Study of their Anti-Microbial Activity. Research J. Pharm. and Tech. 2015; 8(4): April, 407-415. doi: 10.5958/0974-360X.2015.00069.4
23.    Susmi M S, Revathy S Kumar, Sreelakshmi V, Sruthy V Menon, Surya Mohan, Saranya Tulasidharan Suja, Sathianarayanan, Asha Asokan Manakadan. A Computational approach for identification of Phytochemicals for targeting and optimizing the inhibitors of Heat shock proteins. Research J. Pharm. and Tech. 2015; 8(9). Sept. 1199-204. doi: 10.5958/0974-360X.2015.00219.X  
24.    Manoharan Sharanya, Mahendran Radha, Jeyabaskar Suganya, Uma Mageshwari. R. An in silico determination of Drug-Like Molecules from Plant Source to Treat Leprosy- A Neglected Tropical Infectious Disease of India. Research J. Pharm. and Tech. 2017; 10(10): 3361-3364. doi:10.5958/0974-360X.2017.00597.2
25.    Animisha Mokkapati, Radha Krishna Nagumantri, Chinna Babu Pydi, Ramakrishna Chintala, Satyanarayana Rentala. Docking Studies of Piperine-Vitamin a Conjugate to Study the Increase in Bioavailability of Vitamin A. Research J. Pharm. and Tech. 2017; 10(7): 2189-2193.doi: 10.5958/0974-360X.2017.00386.9
26.    Jeyabaskar Suganya, Viswanathan T, Mahendran Radha, Nishandhini Marimuthu. In silico Molecular Docking studies to investigate interactions of natural Camptothecin molecule with diabetic enzymes. Research J. Pharm. and Tech. 2017; 10(9): 2917-22.doi:10.59580974-360X.2017.00515.7
27.    Prem Shankar Misra, V. Ravichandiran, M. Vijey Aanandhi. Design, Synthesis and In Silico Molecular Docking Study of N-carbamoyl-6-oxo-1-phenyl-1, 6-dihydropyridine-3-carboxamide derivatives as Fibroblast growth factor 1 inhibitor. Research J. Pharm. and Tech. 2017; 10(8): 2527-34. doi:10.5958/0974-360X.2017.00447.4
28.    Jeyabaskar Suganya, Sharanya Manoharan, Mahendran Radha, Neha Singh, Astral Francis. Identification and Analysis of Natural Compounds as Fungal Inhibitors from Ocimum sanctum using in silico Virtual Screening and Molecular Docking. Research J. Pharm. and Tech. 2017; 10(10): 3369-3374. doi: 10.5958/0974-360X.2017.00599.6
29.    Silva AKS, Peixoto CA. Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation. Cell Mol Life Sci. 2018; 75: 2951–61.doi: 10.1007/s00018-018-2838-4
30.    Batatinha HAP, Lima EA, Teixeira AAS. Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR-α Knockout Mice. J Cell Physiol. 2017; 232: 1008–19. doi: 10.1002/jcp.25440
31.    Sun X, Zhang Y, Xie M. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease. Acta Pharm. 2017; 67: 1–13. doi: 10.1515/acph-2017-0007
32.    Rigano D, Sirignano C, Taglialatela-Scafati O. The potential of natural products for targeting PPARα.Acta Pharmaceutica Sinica B. 2017; 7: 427–438. doi: 10.1016/j.apsb.2017.05.005

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available